Effects of dapagliflozin on urinary output, fluid balance, and biochemistry in critically ill patients: a post-hoc secondary analysis of the DEFENDER trial.

The effect showed a slight trend from higher values in the dapagliflozin group on day 1 (0.09 mg/dL) to lower values by day 5 (−0.05), but with probabilities of direction that did not strongly support either direction (ranging from 0.39 to 0.73).

also in 4,078 other papers